This study is designed to look at certain blood parameters like biomarkers for predicting the outcome of COVID patients
Recruiting
- Conditions
- Coronavirus as the cause of diseases classified elsewhere,
- Registration Number
- CTRI/2020/10/028436
- Lead Sponsor
- Dr Amarja Havaldar
- Brief Summary
Use ofvarious biomarkers is being investigated and proposed biomarkers are C reactiveprotein CRP, LDH, D Dimer, Ferritin, Troponin I , Procalcitonin and IL 6. Useof these various biomarkers has been studied widely and can be suggested to beused for prognostication. The simple biomarker such as Neutrophil/ Lymphocyteratio also can help in predicting outcome.
The aim of our study is to evaluatethe trend of various biomarkers done for these patients and can it be used topredict the outcome of COVID 19 patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Patients with COVID 19 pneumonia admitted in ICU.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the trend of biomarkers and it’s effect on outcome (ICU mortality)in patients admitted with the diagnosis of COVID pneumonia. ICU mortality or at the end of 4 weeks | Hospital mortality or at the end of 90 days
- Secondary Outcome Measures
Name Time Method 1.To study the number of ventilator free days 2. To study the difference in ICU length of stay
Trial Locations
- Locations (1)
St Johns Medical college
🇮🇳Bangalore, KARNATAKA, India
St Johns Medical college🇮🇳Bangalore, KARNATAKA, IndiaDr Amarja HavaldarPrincipal investigator9036082112amarjahavaldar@rediffmail.com